Clinical Trial Update: Role of FXR in Hepatitis C Virus Replication [NA]

View source ↗

Summary

The clinical trial investigating the role of FXR in Hepatitis C virus replication has been terminated; no results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Chronic Hepatitis C | NA | Status: TERMINATED